60 Degrees Pharmaceuticals Inc. (SXTP)
NASDAQ · Healthcare
60 Degrees Pharmaceuticals Inc. Long Term Debt 2020–2025
60 Degrees Pharmaceuticals Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- 60 Degrees Pharmaceuticals Inc. long term debt as of December 31, 2025: 144,003, a 2.12% decrease year-over-year.
- 60 Degrees Pharmaceuticals Inc. long term debt for 2025 were 144,003, a 2.12% decrease from 2024.
- 60 Degrees Pharmaceuticals Inc. long term debt for 2024 were 147,119, a 2.08% decrease from 2023.
- 60 Degrees Pharmaceuticals Inc. long term debt for 2023 were 150,251, a 88.17% decrease from 2022.
- 60 Degrees Pharmaceuticals Inc. long term debt for 2022 were 1.3M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| 60 Degrees Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $0 |
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $1 |
| 2021 | $19 |
| 2020 | $16 |
60 Degrees Pharmaceuticals Inc. Long Term Debt — FAQ
60 Degrees Pharmaceuticals Inc. (SXTP) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SXTP's long term debt history?
The chart and table above show 60 Degrees Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.